Startups
Amalgent is a fixed-dose combination therapeutics company developing alternatives to traditional opioid pain medications. The Company is developing combination products the provide effective analgesia at dramatically reduced doses. By reducing the dose, Amalgent's products minimize side effects like respiratory depression, confusion, constipation and addiction.
Overview
Location
United States, North Carolina, Greenville
Employees
1-10
Total raised
$250K
Founded date
2020
Investors 1
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 1
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
Reviews 0
FAQ about Amalgent Therapeutics, Inc.
When was Amalgent Therapeutics, Inc. founded?
Amalgent Therapeutics, Inc. was founded in 2020.
How much funding has Amalgent Therapeutics, Inc. raised?
Amalgent Therapeutics, Inc. has raised $250K in total across 1 funding round.
Is Amalgent Therapeutics, Inc. still active?
Yes, Amalgent Therapeutics, Inc. is active; its latest activity on Parsers VC dates from Feb 19, 2025.